Vyome Holdings, Inc. (HIND)
NASDAQ: HIND · Real-Time Price · USD
4.980
+0.210 (4.40%)
At close: Nov 21, 2025, 4:00 PM EST
4.830
-0.150 (-3.01%)
After-hours: Nov 21, 2025, 7:47 PM EST
Vyome Holdings Revenue
Vyome Holdings had revenue of $49.95K in the quarter ending June 30, 2025, with 46.88% growth. This brings the company's revenue in the last twelve months to $394.49K, up 30.16% year-over-year. In the year 2024, Vyome Holdings had annual revenue of $256.94K, down -38.23%.
Revenue (ttm)
$394.49K
Revenue Growth
+30.16%
P/S Ratio
81.57
Revenue / Employee
$19,144
Employees
18
Market Cap
28.11M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 256.94K | -159.00K | -38.23% |
| Dec 31, 2023 | 415.94K | 33.08K | 8.64% |
| Dec 31, 2022 | 382.87K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionHIND News
- 4 days ago - Vyome Holdings Announces Transformational First Quarter Following Nasdaq Listing - Business Wire
- 17 days ago - Biomarker Deals Accelerate: Strategic Alliances Reshape Life Sciences Innovation - GlobeNewsWire
- 18 days ago - Vyome Holdings Announces Results of Annual Shareholder Meeting - Business Wire
- 7 weeks ago - Vyome Holdings Acquires MIT AI Spinout Oculo Health - Business Wire
- 2 months ago - Vyome Presents Strong Data Showing Topical VT-1908 is an Effective Treatment for Uveitis, Opening Up a $3B Addressable Market Opportunity - Business Wire
- 2 months ago - Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial Studies - Business Wire
- 2 months ago - Vyome Holdings Announces Positive Interim Data from Phase 2 Study of VT-1953 in Malignant Fungating Wounds (MFW) and Provides Update on MFW market opportunity - Business Wire
- 3 months ago - Vyome Signs MoU with Embryyo, India's Leading Medical Device Innovation Studio - Business Wire